typ : |
Czasopismo |
link internetowy : |
https://ijpc.com/Abstracts/Abstract.cfm?ABS=4750 |
|
Zespoły badawcze : |
Sydney - National Institute of Complementary Medicine, Western Sydney University |
Autorzy : |
Jarouche M, Ibrahim M, Pearson J, Venkataya B, Low M, Rowe J. |
Tytuł : |
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets. |
Numer : |
Int J Pharm Compound ;24,1:77-82 2020 |
|
Poziom wiarygodności : |
|
stabilność fizyczną : |
|
Stabilność chemiczna : |
|
Inne metody : |
|
Komentarze : |
|
Listy
Metronidazole
|
|
|
|
|
3000 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|
|
3000 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
4°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
4°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
150 mg ® = ? |
|
25°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|
|
150 mg ® = ? |
|
4°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|